Short CV
| Born 1960, married, 2 children |
| Started my scientific carrier on the field of analytical chemistry and biosensorics in Halle/S. and Tübingen, Germany |
1995 | Joined the group of Prof. Solon Thanos at the University Eye Hospital in Tübingen, work on neurocompatible surface modifications and detection of nitric oxide |
1997 | moved with Solon Thanos to the University Eye Hospital Münster, Germany |
2001 | Habilitation in Münster: neuroprotection of axotomised retinal ganglion cells (RGC) and regeneration of RGC axons in rats |
2003-2005 | Laboratory head in the Ophthalmic research disease area at the Novartis Institute of Biomedical Research in Basel, Switzerland, on animal models of retinal degeneration |
2005-2010 | Research associate at the Centre for Ophthalmology in Tübingen, Section of Experimental vitreoretinal surgery, work on the retinal pigment epithelium, visual electrophysiology in small rodents, retinal degeneration |
since 2010 | Laboratory head at the University Eye Hospital in Münster |
- degeneration of retinal ganglion cells and photoreceptors
- neuroprotection and regeneration for restoration of vision
- visual electrophysiology in small rodents
- age-related processes in back of the eye and the immune system
- Association for Research in Vision and Ophthalmology (ARVO)
- German Society for Neuroscience
- German Society for Ophthalmology
Peter Heiduschka |
Key Publications
- P. Heiduschka, S. Schnichels, N. Fuhrmann, S. Hofmeister, U. Schraermeyer, B. Wissinger, M.V. Alavi
Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.
Invest Ophthalmol Vis Sci. 51 (2010) 1424-1431 - P. Heiduschka & U. Schraermeyer
Comparison of visual function in pigmented and albino rats by electroretinography and visual evoked potentials.
Graefe’s Arch. Clin. Exp. Ophthalmol. 246 (2008) 1559-1573 - P. Heiduschka, S. Julien, S. Hofmeister, K.U. Bartz-Schmidt, U. Schraermeyer
Bevacizumab (Avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.
Retina 28 (2007) 46-55 - P. Heiduschka, H. Fietz, S. Hofmeister, S. Schultheiß, A. Mack, S. Peters, F. Ziemssen, B. Niggemann, S. Julien, K.U. Bartz-Schmidt, U. Schraermeyer
Penetration of bevacizumab through the retina after intravitreal injection in monkey.
Invest. Ophthalmol. Vis. Sci. 48 (2007) 2814-2823 - P. Heiduschka & S. Thanos
Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid.
Graefe’s Arch. Clin. Exp. Ophthalmol. 244 (2006) 1512-1521 - P. Heiduschka, D. Fischer & S. Thanos
Recovery of visual evoked potentials after regeneration of cut retinal ganglion cell axons within the ascending visual pathway in adult rats
Restor. Neurol. Neurosci. 23 (2005) 303-312 - P. Heiduschka, D. Fischer & S. Thanos
Neuroprotection and regeneration after traumatic lesion of the optic nerve
Klin. Monatsbl. Augenheilkd. 221 (2004) 684-701 - F. Turcu, K. Tratsk-Nitz, S. Thanos, W. Schuhmann & P. Heiduschka
Ink-jet printing for micropattern generation of laminin for neuronal adhesion.
J. Neurosci. Meth. 131 (2003) 141-148 - M. Groppe, S. Thanos, W. Schuhmann & P. Heiduschka
Measurement of nitric oxide production by the lesioned rat retina with a sensitive nitric oxide electrode.
Anal. Bioanal. Chem. 376 (2003) 797-807 - P. Heiduschka, I. Romann, T. Stieglitz & S. Thanos
Perforated microelectrode arrays implanted in the regenerating adult central nervous system
Exp. Neurol. 171 (2001) 1-10
Research Groups
People